Notice ID: cc0c30e85fe14eaabab8d775dbacbeb6Combined Synopsis/Solicitation
To provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics, drug-device combination products, and contrast agents.
Archived on August 29, 2020. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:00 PM UTC−04:00
- Posted
- August 4, 2020
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH
- Place of performance
- Silver Spring, MD, 20993
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Apr 29, 2026
Identifiers
- Solicitation number
- FDASOL1222072
- Notice ID
- cc0c30e85fe14eaabab8d775dbacbeb6
Description
See attachments for detail
Award Overview
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDASOL1222072- Combined Synopsis
- Combined SynopsisCurrentAug 4, 2020
To provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics, drug-device combination products, and contrast agents.
Similar Opportunities
Additional Details
Solicitation Number
FDASOL1222072
Archive Date
Aug 29, 2020
Office Address
Silver Spring, MD, 20993